Galyn Forster, MS, LPC - Treatment of Psychiatric Disorders (2016 Conference) (LDN, low dose naltrexone)

Download Mr. Forster's Psych Disorders Presentation

 

Drug Resistant Depression - Elizabeth Livengood, NMD (2021 Conference) (LDN, low dose naltrexone)

Dr. Elizabeth Livengood’s presentation is on identifying different causes of depression, identifying depression, hyperthyroidism connections, identifying patient profiles who fit these descriptions, and understanding how to treat them. 

 

Early Biomarkers of a Brain on Fire - Tom O’Bryan, DC, CCN, DACBN (2021 Conference) (LDN, low dose naltrexone)

LDN Research Trust 2021 Conference - Friday Morning

 

History, Pharmacology and Mechanism - Stephen Dickson, BSC (hons) MRPharmS (2021 Conference) (LDN, low dose naltrexone)

LDN Research Trust 2021 Conference - Friday Morning

 

Wiebke Pape, MD - A Medication to Gain Self-Awareness: Treatment of Dissociative Symptoms in Trauma-Related Disorder II (2017 Conference) (LDN, low dose naltrexone)

 

Mark Shukhman, MD - LDN for treatment of Postcoital Dysphoria (2017 Conference) (LDN, low

Dr Shukhman explains the impact that LDN can have upon the body’s sex hormones in terms of psychology and performance.

 

Jill Cottel, MD - LDN for Alcohol Use Disorder (2017 Conference) (LDN, low dose naltrexone)

Dr Jill Cottel: Hello everyone. This is Dr Jill Cottell. I'm an internal medicine doctor from Poway in California. As always, it is my pleasure and privilege to work with the LDN Research Trust.

 

Ginevra Liptan, MD - Alternative Strategies for Fibromyalgia Pain (2017 Conference) (LDN, low dose naltrexone)

 

Galyn Forster, MS, LPC - An Introduction to Phobia of Shared Positive Affect (2017 Conference) (LDN, low dose naltrexone)

Most common phobia is phobia of shared positive affect: avoiding experiences that invoke positive emotions or happiness. Causes, related disorders; coincidence with alcohol use disorder. Case discussion. Diagnostic traits, therapeutic approaches.

 

Ulrich Lanius, PhD - Naltrexone Dosing in Traumatic Stress and Dissociative Symptoms (2019 Conference) (LDN, low dose naltrexone)